-
2015Global Gene Expression Profiling through the Complete Life Cycle of Trypanosoma vivax, PLoS Negl Trop Dis 2015 Aug;9(8):e0003975.
-
2015Phylogenetic and syntenic data support a single horizontal transference to a Trypanosoma ancestor of a prokaryotic proline racemase implicated in parasite evasion from host defences, Parasit Vectors 2015;8:222.
-
2013A combined luciferase-expressing Leishmania imaging/RT-qPCR assay provides new insights into the sequential bilateral processes deployed in the ear pinna of C57BL/6 mice, Parasitol. Int. 2014 Feb;63(1):245-53.
-
2013In vivo imaging of trypanosomes for a better assessment of host-parasite relationships and drug efficacy, Parasitol. Int. 2014 Feb;63(1):260-8.
-
2013Reprogramming neutral lipid metabolism in mouse dendritic leucocytes hosting live Leishmania amazonensis amastigotes, PLoS Negl Trop Dis 2013;7(6):e2276.
-
2013Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas’ disease, PLoS ONE 2013;8(4):e60955.
-
2013Non-invasive in vivo study of the Trypanosoma vivax infectious process consolidates the brain commitment in late infections, PLoS Negl Trop Dis 2013;7(1):e1976.
-
2011Genetic engineering of Trypanosoma (Dutonella) vivax and in vitro differentiation under axenic conditions, PLoS Negl Trop Dis 2011 Dec;5(12):e1461.
-
2011Drug discovery targeting amino acid racemases, Chem. Rev. 2011 Nov;111(11):6919-46.
-
2011Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro, PLoS Negl Trop Dis 2011 Sep;5(9):e1323.
-
2010A combined luciferase imaging and reverse transcription polymerase chain reaction assay for the study of Leishmania amastigote burden and correlated mouse tissue transcript fluctuations, Cell. Microbiol. 2011 Jan;13(1):81-91.
-
2010Trypanosoma vivax infections: pushing ahead with mouse models for the study of Nagana. II. Immunobiological dysfunctions, PLoS Negl Trop Dis 2010;4(8).
-
2010Trypanosoma vivax infections: pushing ahead with mouse models for the study of Nagana. I. Parasitological, hematological and pathological parameters, PLoS Negl Trop Dis 2010;4(8):e792.
-
2010Intravenous immunoglobulin increases survival time in the acute phase of experimental Chagas disease, Parasite Immunol. 2010 Jun;32(6):464-9.
-
2009Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity, Antimicrob. Agents Chemother. 2010 Mar;54(3):984-90.
-
2009Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection, Mem. Inst. Oswaldo Cruz 2009 Dec;104(8):1055-62.
-
2009Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection, Mem. Inst. Oswaldo Cruz 2009 Dec;104(8):1055-62.
-
2009Sorting of Leishmania-bearing dendritic cells reveals subtle parasite-induced modulation of host-cell gene expression, Microbes Infect. 2010 Jan;12(1):46-54.
-
2009Imaging Leishmania development in their host cells, Trends Parasitol. 2009 Oct;25(10):464-73.
-
2009Proline racemases: insights into Trypanosoma cruzi peptides containing D-proline, Mem. Inst. Oswaldo Cruz 2009 Jul;104 Suppl 1:295-300.
-
2009Proline racemases are conserved mitogens: characterization of a Trypanosoma vivax proline racemase, Mol. Biochem. Parasitol. 2009 Jun;165(2):170-9.
-
2008AffyGCQC: a web-based interface to detect outlying genechips with extreme studentized deviate tests, J Bioinform Comput Biol 2008 Apr;6(2):317-34.
-
2007Molecular and structural discrimination of proline racemase and hydroxyproline-2-epimerase from nosocomial and bacterial pathogens, PLoS ONE 2007;2(9):e885.
-
2006Crystal structure, catalytic mechanism, and mitogenic properties of Trypanosoma cruzi proline racemase, Proc. Natl. Acad. Sci. U.S.A. 2006 Feb;103(6):1705-10.
-
2005Trypanosoma cruzi proline racemases are involved in parasite differentiation and infectivity, Mol. Microbiol. 2005 Oct;58(1):46-60.
-
2003Biochemical characterization of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition of putative protein signatures, J. Biol. Chem. 2003 May;278(18):15484-94.
-
2002Immunotherapy of Trypanosoma cruzi infections, Curr. Drug Targets Immune Endocr. Metabol. Disord. 2002 Oct;2(3):247-54.
-
2002Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin, Infect. Immun. 2002 Sep;70(9):5115-23.
-
2001Parasite polyclonal activators: new targets for vaccination approaches?, Int. J. Parasitol. 2001 May;31(5-6):588-91.
-
2001Significant association between the skewed natural antibody repertoire of Xid mice and resistance to Trypanosoma cruzi infection, Eur. J. Immunol. 2001 Feb;31(2):634-45.
-
2000A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase, Nat. Med. 2000 Aug;6(8):890-7.
-
2000Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents, Parasitol. Today (Regul. Ed.) 2000 Feb;16(2):62-7.
-
2000Changes in the cytokine profile of lupus-prone mice (NZB/NZW)F1 induced by Plasmodium chabaudi and their implications in the reversal of clinical symptoms, Clin. Exp. Immunol. 2000 Feb;119(2):333-9.
-
1999Theileria annulata in CD5(+) macrophages and B1 B cells, Infect. Immun. 1999 Dec;67(12):6678-82.
-
1999A Trypanosoma cruzi alkaline antigen induces polyclonal B-cell activation of normal murine spleen cells by T-cell-independent, BCR-directed stimulation, Scand. J. Immunol. 1999 Aug;50(2):159-66.
-
1999Partial protection of mice against Trypanosoma cruzi after immunizing with the TcY 72 antigenic preparation, Mem. Inst. Oswaldo Cruz 1999 Mar-Apr;94(2):167-72.
-
1999X-linked immunodeficiency affects the outcome of Schistosoma mansoni infection in the murine model, Parasite Immunol. 1999 Feb;21(2):89-101.
-
1998A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator, Immunology 1998 Jun;94(2):189-96.
-
1997Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice, Infect. Immun. 1997 Feb;65(2):457-65.
-
1996V beta 6-bearing T cells are involved in resistance to Trypanosoma cruzi infection in XID mice, Int. Immunol. 1996 Aug;8(8):1213-9.
-
1996Murine acariasis. II. Immunological dysfunction and evidence for chronic activation of Th-2 lymphocytes, Scand. J. Immunol. 1996 Jun;43(6):604-12.
-
1996The influence of T cell subsets on Trypanosoma cruzi multiplication in different organs, Immunol. Lett. 1996 Mar;49(3):163-8.
-
1996Ig-isotype patterns of primary and secondary B cell responses to Plasmodium chabaudi chabaudi correlate with IFN-gamma and IL-4 cytokine production with CD45RB expression by CD4+ spleen cells, Scand. J. Immunol. 1996 Mar;43(3):263-70.
-
1996Intranasal inoculation of Bordetella bronchiseptica in mice induces long-lasting antibody and T-cell mediated immune responses, Scand. J. Immunol. 1996 Feb;43(2):181-92.
-
1996Chagas’ disease is attenuated in mice lacking gamma delta T cells, Infect. Immun. 1996 Jan;64(1):215-21.
-
1995The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice, Immunology 1995 Aug;85(4):556-61.
-
1995Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis, Immunology 1995 May;85(1):26-32.
-
1995In vivo evidence for a non-T cell origin of interleukin-5, Scand. J. Immunol. 1995 Mar;41(3):288-92.
-
1994Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection, Infect. Immun. 1994 Sep;62(9):3962-71.
-
1994Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology, Proc. Natl. Acad. Sci. U.S.A. 1994 Aug;91(17):8097-101.
-
1994Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice, Immunology 1994 Jul;82(3):361-4.
-
1994Increase of B-lymphocyte number and activity during experimental murine schistosomiasis mansoni, Braz. J. Med. Biol. Res. 1994 Jul;27(7):1605-17.
-
1994Skewed V beta TCR repertoire of CD8+ T cells in murine Trypanosoma cruzi infection, Int. Immunol. 1994 Mar;6(3):387-92.
-
1994Endogenous IL-10 and IFN-gamma production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi, Scand. J. Immunol. 1994 Jan;39(1):51-8.
-
1993Xid-associated resistance to experimental Chagas’ disease is IFN-gamma dependent, J. Immunol. 1993 Oct;151(8):4200-8.
-
1992CD5 B cells. Potential role in the (auto)immune responses to Trypanosoma cruzi infection, Ann. N. Y. Acad. Sci. 1992 May;651:557-63.
-
1992V-region-related and -unrelated immunosuppression accompanying infections, Mem. Inst. Oswaldo Cruz 1992;87 Suppl 5:35-41.
-
1991Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas’ disease, Int. Immunol. 1991 May;3(5):427-33.
-
1991Chagas’ disease: Trypanosoma cruzi vs. the host immune system, Res. Immunol. 1991 Feb;142(2):125-6.
-
1991Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice?, Res. Immunol. 1991 Feb;142(2):117-22.
-
1991Chagas’ disease: CD5 B-cell-dependent Th2 pathology?, Res. Immunol. 1991 Feb;142(2):137-40.
-
1989Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells, Immunol. Rev. 1989 Dec;112:183-207.
-
1989Further phenotypic characterization of target cells for bovine leukemia virus experimental infection in sheep, Am. J. Vet. Res. 1989 Nov;50(11):1946-51.
-
1989Susceptible mice present higher macrophage activation than resistant mice during infections with myotropic strains of Trypanosoma cruzi, Parasite Immunol. 1989 Jul;11(4):385-95.
-
1989Indiscriminate representation of VH-gene families in the murine B lymphocyte responses to Trypanosoma cruzi, J. Immunol. 1989 Jun;142(11):4017-21.
-
1989Preferential expansion of Ly-1 B and CD4- CD8- T cells in the polyclonal lymphocyte responses to murine T. cruzi infection, Int. Immunol. 1989;1(2):176-84.
-
1988Most B cells in acute Trypanosoma cruzi infection lack parasite specificity, Scand. J. Immunol. 1988 Nov;28(5):553-61.
-
1988Lymphocyte subpopulations and clonal repertoires participate in immune response to acute T. cruzi infection, Mem. Inst. Oswaldo Cruz 1988 Nov;83 Suppl 1:356-9.
-
1988Depletion of L3T4+ T lymphocytes during acute Trypanosoma cruzi infection abolish macrophage and B lymphocyte activation but not tissue inflammatory reaction, Mem. Inst. Oswaldo Cruz 1988 Nov;83 Suppl 1:527-38.
-
1988Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells, Ann. Inst. Pasteur Immunol. 1988 May-Jun;139(3):225-36.
-
1987Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies, J. Immunol. 1987 Jul;139(2):545-50.
-
1986Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. II. Cytotoxic T lymphocytes, Scand. J. Immunol. 1986 Dec;24(6):669-79.
-
1986Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses, Scand. J. Immunol. 1986 Dec;24(6):661-8.
-
1986Persistence of polyclonal B cell activation with undetectable parasitemia in late stages of experimental Chagas’ disease, J. Immunol. 1986 Jul;137(1):353-6.
-
1986Vascular irradiation damage: its cellular basis and likely consequences, Br. J. Cancer Suppl. 1986;7:181-91.
-
1980In vitro study of immunological events in human and experimental schistosomiasis: relationships between cytotoxic antibodies and circulating Schistosoma antigens, Parasite Immunol. 1980;2(3):223-35.